Providing Low-barrier Addiction Treatment Via a Telemedicine Consultation Service During the COVID-19 Pandemic in Los Angeles, County: An Assessment 1 Year Later

Abstract

Background Los Angeles County Department of Health Services provides medical care to a diverse group of patients residing in underresourced communities. To improve patients' access to addiction medications during the COVID-19 pandemic, Los Angeles County Department of Health Services established a low-barrier telephone service for DHS providers in March 2020, staffed by DATA-2000–waivered providers experienced with prescribing addiction medications. This study describes the patient population and medications prescribed through this service during its initial 12 months. Methods We performed a retrospective evaluation of a provider-entered call registry for the telephone consult line. Information was collected between March 31, 2020, and March 30, 2021. The registry includes information related to patient demographics, the reason for visit, and which addiction medications were prescribed. We conducted descriptive statistics in each of these domains. Results During the study period, 11 providers on the MAT telephone service logged 713 calls. These calls represented a total of 557 unique patients (mean age of 40 years, 75% male, 41% Latino, 49% experiencing homelessness). Most patients either had Medicaid insurance (77%) or were uninsured (20%). The most prescribed addiction medication was buprenorphine-naloxone (90%), followed by nicotine replacement therapy (5.3%), naltrexone (4.2%), and buprenorphine monotherapy (1.8%). Conclusion A telephone addiction medication service is feasible to deliver low-barrier medications to treat addiction in underresourced communities, especially to individuals experiencing homelessness. This can mitigate but does not eliminate disparities in access to addiction medications for communities of color.

Developing a Theoretically Informed Implementation Model for Telemedicine-Delivered Medication for Opioid Use Disorder: Qualitative Study With Key Informants

“…For example, concerns have been raised over audio-only versus video-based telemedicine being less efficient and effective [ 86 ]. Regulators in the United States are considering mandating against audio-based TMOUD despite better engagement of people at the extreme margins of society [ 87 , 88 ]. However, the implication for developing video-only models of TMOUD may include the marginalization of those who feel able to use the telephone to receive care even if data-heavy mobile apps or video calls are unaffordable or unappealing.…”

Telemedication for Opioid Use Disorder: A New Approach for Treatment

“… 5 Although these services were implemented to meet the needs of patients during the pandemic, tele-MOUD also addressed many barriers to care that had previously hindered individuals from accessing treatment for OUD, including transportation challenges, employment obligations, or education responsibilities. 6 …”

A mobile addiction service for community-based overdose prevention

“…Patients with opioid use disorders (OUD) face multiple individualized and systemic barriers to treatment ( 6 ), including long waiting periods for appointments and keeping appointments due to low treatment capacity among healthcare institutions ( 7 ), inconsistent access to telephones and transportation ( 8 ), and challenges with insurance and personal identification. Prior experiences of stigma in healthcare settings further complicates the engagement of patients with OUD into traditional care paradigms ( 9 ).…”